Yingjiao Cao
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
FXR-mediated antigen-specific CD8+ T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 23, 2025
FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus.
Journal: Cellular & molecular immunology
Published: December 11, 2024
DOCK2 protects against bacterial sepsis by constraining T helper 1 response.
Journal: Frontiers in immunology
Published: November 14, 2024
Single-cell transcriptomic analysis reveals heterogeneous features of myeloid-derived suppressor cells in newborns.
Journal: Frontiers in immunology
Published: January 08, 2024
Dopamine Receptor 1 Impedes ILC2-Mediated Antitumor Immunity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 28, 2023
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.
Journal: Vaccine
Published: January 28, 2023
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy.
Journal: Nature cancer
Published: January 17, 2023
Retinoid X receptor gamma dictates the activation threshold of group 2 innate lymphoid cells and limits type 2 inflammation in the small intestine.
Journal: Immunity
Published: September 14, 2022
Mechanisms regulating transitory suppressive activity of neutrophils in newborns: PMNs-MDSCs in newborns.
Journal: Journal of leukocyte biology
Published: September 27, 2021
Last Updated: 09/26/2026